Search - Archive ouverte HAL Access content directly

Filter your results

14 Results
authFullName_s : Thomas Berg

Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE)

Milan Sonneveld , Jun Yong Park , Apichat Kaewdech , Wai-Kay Seto , Yasuhito Tanaka et al.
Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.e784-e793. ⟨10.1016/j.cgh.2020.12.005⟩
Journal articles hal-04012155v1

Update of the statements on biology and clinical impact of occult hepatitis B virus infection

Giovanni Raimondo , Stephen Locarnini , Teresa Pollicino , Massimo Levrero , Fabien Zoulim et al.
Journal of Hepatology, 2019, 71 (2), pp.397-408. ⟨10.1016/j.jhep.2019.03.034⟩
Journal articles hal-02370703v1

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

Philippe Merle , Jean-Frederic Blanc , Jean-Marc Phélip , Gilles Pelletier , Jean-Pierre Bronowicki et al.
The Lancet Gastroenterology & Hepatology, 2019, 4 (6), pp.454-465. ⟨10.1016/S2468-1253(19)30040-8⟩
Journal articles hal-02262527v1

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study

Pietro Lampertico , Thomas Berg , Maria Buti , Anita Pathil , Joerg Petersen et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2020, 52 (3), pp.500-512. ⟨10.1111/apt.15901⟩
Journal articles hal-03933002v1
Image document

Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B

Issam Tout , Pietro Lampertico , Thomas Berg , Tarik Asselah
Antiviral Research, 2021, 185, pp.104992 -. ⟨10.1016/j.antiviral.2020.104992⟩
Journal articles hal-03493469v1

Characterization and subcellular localization of human neutral class II alpha-mannosidase cytosolic enzymes

Elina Kuokkanen , Wesley Smith , Marika Mäkinen , Heidi Tuominen , Maija Puhka et al.
Glycobiology, 2007, 17 (10), pp.1084-1093
Journal articles hal-00250062v1

Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1

Hamish Innes , Stephan Buch , Sharon Hutchinson , Indra Neil Guha , Joanne Morling et al.
Gastroenterology, 2020, 159 (4), pp.1276-1289.e7. ⟨10.1053/j.gastro.2020.06.014⟩
Journal articles hal-03691801v1

SILEN-C3, a Phase 2 Randomized Trial with Faldaprevir plus Pegylated Interferon α-2a and Ribavirin in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients

Douglas T. Dieterich , Tarik Asselah , Dominique Guyader , Thomas Berg , Marcus Schuchmann et al.
Antimicrobial Agents and Chemotherapy, 2014, 58 (6), pp.3429-3436. ⟨10.1128/AAC.02497-13⟩
Journal articles hal-03562700v1

The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis

Hamish Innes , Hans Dieter Nischalke , Indra Neil Guha , Karl Heinz Weiss , Will Irving et al.
International Hepatology Communications, 2022, 6 (5), pp.1213-1226. ⟨10.1002/hep4.1886⟩
Journal articles hal-03691807v1

Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties

Rajiv G. Tawar , Che C. Colpitts , Jörg Timm , Tanja Fehm , Michael Roggendorf et al.
Hepatology, 2015, 62 (3), pp.726-736. ⟨10.1002/hep.27906⟩
Journal articles hal-01908875v1

Assistance of Microbial Glycolipid Antigen Processing by CD1e

Henri de La Salle , Sabrina Mariotti , Catherine Angénieux , Martine Gilleron , Luis Fernando Garcia-Alles et al.
Science, 2005, 310 (5752), pp.1321-1324. ⟨10.1126/science.1115301⟩
Journal articles hal-03003514v1

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

Milan Sonneveld , Shao-Ming Chiu , Jun Yong Park , Sylvia Brakenhoff , Apichat Kaewdech et al.
Journal of Hepatology, 2022, 76 (5), pp.1042-1050. ⟨10.1016/j.jhep.2022.01.007⟩
Journal articles hal-04013069v1

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.

Michael P Manns , Marc Bourlière , Yves Benhamou , Stanislas Pol , Maurizio Bonacini et al.
Journal of Hepatology, 2011, 54 (6), pp.1114-22. ⟨10.1016/j.jhep.2010.08.040⟩
Journal articles istex hal-00850685v1

Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B

Heejoon Jang , Jun Sik Yoon , Soo Young Park , Han Ah Lee , Myoung-Jin Jang et al.
Clinical Gastroenterology and Hepatology, 2022, 20 (6), pp.1343-1353.e16. ⟨10.1016/j.cgh.2021.09.001⟩
Journal articles hal-04012226v1